Login to Your Account



Financings Roundup


Tuesday, October 25, 2011
DLVR Therapeutics Inc., of Toronto, completed its seed round investment, bringing the total raised to $2 million in cash and in-kind support. MaRS Innovation joined the University Health Network and the Ontario Institute for Cancer Research (OICR) as investors in the privately held company.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription